Animal models of immune-mediated demyelinating polyneuropathies

Eroboghene E Ubogu1

  • 1Neuromuscular Immunopathology Research Laboratory, Division of Neuromuscular Disease, Department of Neurology, University of Alabama at Birmingham, Birmingham, AL, USA.

Autoimmunity
|June 8, 2024
PubMed
Summary

Immune-mediated demyelinating polyneuropathies (IMDPs) are rare, and while progress has been made, specific therapies are lacking. Research using novel mouse models offers insights into autoimmune disease triggers and potential therapeutic targets.